ERIS Quarterly Results, Profit & Loss, Balance Sheet (ERIS)

ERIS quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • ERIS Financials
  • ERIS Shareholding Pattern
  • ERIS Earnings Documents
  • ERIS Announcements
  • ERIS Corporate Actions
  • ERIS Bulk, Block & Insider Deals
  • ERIS Delivery Data
  • ERIS Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Eris Lifesciences Ltd (ERIS) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Eris Lifesciences Ltd reported sales of ₹892 Cr, operating profit of ₹308 Cr (OPM 35%) and net profit of ₹187 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

ERIS quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales727705773792807757873892
Expenses477453496504526484577584
Operating Profit250252277288282272296308
OPM34%36%36%36%35%36%34%35%
Other Income4843-1722-33
Interest5754495049464746
Depreciation8177716970707273
Profit before tax116129161173145159179156
Tax25%21%22%22%25%-75%20%-20%
Net Profit87102125134109279143187
EPS in Rs6.156.898.668.827.3220.3310.2813.25
ERIS profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,3471,6852,0092,8943,1293,330
Expenses8581,1461,3321,8762,0092,171
Operating Profit4895396771,0181,1201,158
OPM36%32%34%35%36%35%
Other Income2292218-9-45
Interest42685231193188
Depreciation65117183315280285
Profit before tax442405431489639640
Tax8%8%8%23%-1%-
Net Profit406374397375648718
EPS in Rs29.8828.128.8225.8444.7251.18
Dividend Payout20%26%0%28%16%-
ERIS balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital1414141414
Reserves2,5732,8413,0783,8894,130
Borrowings2,7812,4782,3892,3592,430
Other Liabilities1,3661,4151,6808611,007
Total Liabilities6,7346,7477,1607,1237,581
Fixed Assets4,3195,3065,2175,1884,869
CWIP2067122171395
Investments1667686260
Other Assets2,3791,3071,7531,7022,257
Total Assets6,7346,7477,1607,1237,581
ERIS cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity3782924861,065538
Cash from Investing Activity-320-975-1,828-78-369
Cash from Financing Activity-456881,380-881-314
Net Cash Flow14538105-145
Free Cash Flow258-550357910241
CFO/OP94%68%87%114%59%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit94688711459
ERIS ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days4463775879
Inventory Days166136182171200
Days Payable166129210170151
Cash Conversion Cycle44704859129
Working Capital Days7550-296-49-71
ROCE25%17%11%12%14%
  • ERIS Shareholding Pattern
  • ERIS Earnings Concalls
  • ERIS Growth Catalysts
  • ERIS Corporate Actions
  • ERIS Announcements
  • ERIS Results & Documents
  • ERIS Bulk & Block Deals
  • ERIS Delivery Data